Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Genus PLC Director's Dealing 2026

May 13, 2026

4873_dirs_2026-05-13_222a3715-9d1d-4f5d-9428-c19746b821d8.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2006E

Genus PLC

13 May 2026

13 May 2026

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that further to the vesting on 4 May 2026 of 7,649 nil-cost options granted over ordinary shares on 2 May 2023 in respect of buyout of compensation forfeited from his previous employer, Jorgen Kokke, Chief Executive Officer, exercised 7,649 nil-cost options on 13 May 2026.

As listed in table A below, Jorgen Kokke sold 3,450 ordinary shares in Genus on 13 May 2026 on the London Stock Exchange to offset income tax and social security liabilities due on the exercise of those vested options and retained the balance of 4,199 ordinary shares.

The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 13 May 2026.

For further information please contact:

Genus:

Vaughn Walton, Deputy Company Secretary                                       Tel: +44 (0)1256 347100

Table A - Exercise of buy-out awards vesting on 13 May 2026

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

Jorgen Kokke

2.            

Reason for the notification

a.            

Position/status

Chief Executive

b.            

Initial notification

/Amendment

Initial notification

3.            

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.           

LEI

54930022EOITNKSIGH56

4.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.            

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.            

Nature of the transaction

Exercise of nil-cost options granted on 2 May 2023 over ordinary shares in Genus in respect of buyout of compensation forfeited from his previous employer.

c.            

Price(s) and volume(s)

Price Volume
0p 7,649

d.            

Aggregated information

·    Aggregated volume

·    Price

Price(s) Volume(s)
0p 7,649

e.            

Date of the transaction

2026-05-13

f.            

Place of the transaction

Outside a trading venue.

5.            

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.

Nature of the transaction

Sale of shares arising from the exercise of nil-cost options to offset income tax and social security liabilities due on the exercise.

c.

Price(s) and volume(s)

Price Volume
2,267.9397p 3,450

d.

Aggregated information

·    Aggregated volume

·    Price

Price Volume
2,267.9397p 3,450

e.

Date of the transaction

2026-05-13

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFXLFFQELXBBF